1-5 of 5
Marie-Anne van Lierde
Close
Sort by
Journal Articles

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

Clinical Trials & Observations
Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachée, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2009) 113 (22): 5401–5411.
https://doi.org/10.1182/blood-2008-12-196543
Published: 2009
Journal Articles

Patient Nonadherence and Treatment Response to Imatinib in Patients with Chronic Myeloid Leukemia: Results from the ADAGIO Study

Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachee, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, Laurie Letvak, Ivo Abraham
Journal: Blood
Blood (2008) 112 (11): 2379.
https://doi.org/10.1182/blood.V112.11.2379.2379
Published: 2008
Journal Articles

Multimethod Clinical Assessment of Patterns and Prevalence of Nonadherence (NA) to Imatinib Treatment (IMRx) in Patients (Pts) with Chronic Myeloid Leukemia (CML): Results from the ADAGIO Study.

Marie-Anne van Lierde, Filipo Serra, Larissa De Rop, Eric Strobbe, Karen MacDonald, Stefaan Vancayzeele, Sabina De Geest, Laurie Letvak, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2007) 110 (11): 5163.
https://doi.org/10.1182/blood.V110.11.5163.5163
Published: 2007
Journal Articles

Canonical Correlation Analysis (CCA) of Imatinib Treatment (ImRx) Nonadherence (NA) with Associated Patient Variables (APVs) in Chronic Myeloid Leukemia (CML) - Results from the ADAGIO Study.

Marie-Anne van Lierde, Larissa De Rop, Filipo Serra, Eric Strobbe, Karen MacDonald, Stefaan Vancayzeele, Sabina De Geest, Laurie Letvak, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2007) 110 (11): 5164.
https://doi.org/10.1182/blood.V110.11.5164.5164
Published: 2007
Journal Articles

Promoting Patient (pt) Adherence (PA) with Imatinib Treatment (IMRx) in Chronic Myeloid Leukemia (CML): Physicians (MD) Perceptions of Utility (Effectiveness [FX], Feasibility [FB], Cost [CO]) and Rankings of Clinical Applicability (CAPL) of 13 Adherence-Enhancing Strategies (AESs) - Results from the ADAGIO Study.

Marie-Anne van Lierde, Eric Strobbe, Larissa De Rop, Filipo Serra, MacDonald MacDonald, Stefaan Vancayzeele, Sabina De Geest, Laurie Letvak, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2007) 110 (11): 5165.
https://doi.org/10.1182/blood.V110.11.5165.5165
Published: 2007